Click Here for 5% Off Your First Aladdin Purchase!

Udenafil - 98%, high purity , Phosphodiesterase 5A inhibitor, CAS No.268203-93-6, Phosphodiesterase 5A inhibitor

  • Moligand™
  • ≥98%
Item Number
U333275
Grouped product items
SKUSizeAvailabilityPrice Qty
U333275-50mg
50mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$528.90
U333275-250mg
250mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$2,380.90
U333275-1g
1g
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$8,569.90

PDE5A (phosphodiesterase 5) inhibitor.

View related series
phosphodiesterase 5A Inhibitor

Basic Description

SynonymsUdenafil|268203-93-6|Zydena|DA-8159|L5IB4XLY36|3-(1-methyl-7-oxo-3-propyl-4H-pyrazolo[4,3-d]pyrimidin-5-yl)-N-[2-(1-methylpyrrolidin-2-yl)ethyl]-4-propoxybenzenesulfonamide|CID 6918523|3-(1-methyl-7-oxo-3-propyl-4,7-dihydro-1H-pyrazolo(4,3-d)pyrimidin-5-y
Specifications & Purity98%
Storage TempStore at 2-8°C
Shipped InWet ice
GradeMoligand™
Action TypeINHIBITOR
Mechanism of actionPhosphodiesterase 5A inhibitor
Product Description

Udenafil is an oral phosphodiesterase 5 inhibitor.

Product Properties

pKapKₐ: 3.5 (Predicted)
ALogP3

Associated Targets

PDE5A Tclin cGMP-specific 3',5'-cyclic phosphodiesterase 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name 3-(1-methyl-7-oxo-3-propyl-6H-pyrazolo[4,3-d]pyrimidin-5-yl)-N-[2-(1-methylpyrrolidin-2-yl)ethyl]-4-propoxybenzenesulfonamide
INCHI InChI=1S/C25H36N6O4S/c1-5-8-20-22-23(31(4)29-20)25(32)28-24(27-22)19-16-18(10-11-21(19)35-15-6-2)36(33,34)26-13-12-17-9-7-14-30(17)3/h10-11,16-17,26H,5-9,12-15H2,1-4H3,(H,27,28,32)
InChi Key IYFNEFQTYQPVOC-UHFFFAOYSA-N
Canonical SMILES CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)NCCC4CCCN4C)OCCC)C
Isomeric SMILES CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)NCCC4CCCN4C)OCCC)C
PubChem CID 135413547
Molecular Weight 516.66

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

4 results found

Lot NumberCertificate TypeDateItem
B2426260Certificate of AnalysisJun 20, 2022 U333275
H2224316Certificate of AnalysisJun 20, 2022 U333275
H2224361Certificate of AnalysisJun 20, 2022 U333275
H2224541Certificate of AnalysisJun 20, 2022 U333275

Chemical and Physical Properties

SolubilitySoluble in chloroform, and methanol.
Melt Point(°C)154.0-155.0° C

Related Documents

References

1. Oh TY, Kang KK, Ahn BO, Yoo M, Kim WB.  (2000)  Erectogenic effect of the selective phosphodiesterase type 5 inhibitor, DA-8159..  Arch Pharm Res,  23  (5): (471-6).  [PMID:11059826]
2. Shim HJ, Lee EJ, Kim SH, Kim SH, Yoo M, Kwon JW, Kim WB, Lee HS, Lee MG.  (2000)  Pharmacokinetics, stability, and blood partition of DA-8159, a new phosphodiesterase V inhibitor..  Res Commun Mol Pathol Pharmacol,  108  (3-4): (275-86).  [PMID:11913718]
3. Ahn BO, Kang KK, Ahn GJ, Kwon JW, Kim WB, Kang KS, Lee YS.  (2003)  Efficacy of DA-8159, a new PDE5 inhibitor, for inducing penile erection in rabbits with acute spinal cord injury..  Int J Impot Res,  15  (6): (405-11).  [PMID:14671658]

Solution Calculators